What AI says about Clickotine
Clickotine is a digital therapeutics program for smoking cessation that utilizes the CLICK Neurobehavioral Intervention Platform.
Since Jul 5Updated Nov 10, 2026Based on 470 AI answers
Reviewed by Dimitry Apollonsky
Mentioned in · Public index
5%
of AI answers about Clickotine and its rivals · since Jul 5
Based on 470 AI answers
- ChatGPT4%
- Google AI Mode6%
How often AI mentions Clickotine
of AI answers about Clickotine and its rivals
Track your brand free to see 13 weeks of history.
Use the left and right arrow keys to read each date.
Sep 14OctNov 2
- · ChatGPT switched to GPT-6 Luna
More from Click Therapeutics
BrandMentioned in
- Click Therapeutics11%
- AspyreRx6%
- Clickotine5%
Questions and answers
- AI picks mostMentioned in
- Who offers digital therapeutics for smoking cessation that are clinically validated?on this questionAI picks Clickotine and 1 more about as often57%
Excerpts where Clickotine appeared in the AI's answer
Google AI ModeSep 24, 2026, Google AI Mode Clickotine (by Click Therapeutics) : A comprehensive, prescription-grade digital therapeutic platform
Google AI ModeSep 16, 2026, Google AI Mode Clickotine is a comprehensive, evidence-based digital therapeutic platform designed for smartphone use.
Clickotine in AI answers
Who offers digital therapeutics for smoking cessation that are clinically validated?
ChatGPTChatGPTNo answer mentioning Clickotine
Google AI ModeGoogle AI Mode· Sep 24, 2026
Clickotine (by Click Therapeutics) : A comprehensive, prescription-grade digital therapeutic platform
Sites AI cites
- Your site44%
- Click Therapeutics Announces Collaboration with youturn to Expand Access to Clinically Validated Smoking Cessation Program Clickotine® (opens in a new tab) · 17%
- Click Therapeutics Presents Data on Increased Efficacy of a Digital Therapeutics™ Program for Smoking Cessation at Six-Month Mark of Clinical Trial (opens in a new tab) · 10%
- Magellan Health and Click Therapeutics Launch Fully Digital, Integrated and Comprehensive Smoking Cessation Program (opens in a new tab) · 10%
- Click Therapeutics Announces that Solera Health will Provide Clinically Validated Smoking-Cessation Program Clickotine® to Blue Shield of California Members (opens in a new tab) · 6%
- Click Therapeutics (opens in a new tab) · 1%
- 18%
- Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial - PMC (opens in a new tab) · 4%
- Digital therapeutics in the clinic - PMC - NIH (opens in a new tab) · 3%
- Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation - PMC (opens in a new tab) · 3%
- Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial - PMC (opens in a new tab) · 3%
- Cytisine as an Emerging Tool for Smoking Cessation and Addiction Treatment (opens in a new tab) · 1%
- Exploration of Digital Interventions for Vaping Cessation: Scoping Review (opens in a new tab) · 1%
- Initial Assessment of a Comprehensive Digital Smoking ... (opens in a new tab) · 1%
- Outcomes of a Comprehensive Mobile Smoking Cessation Program With Nicotine Replacement Therapy in Adult Smokers: Pilot Randomized Controlled Trial - PMC (opens in a new tab) · 1%
- 7%
- Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial - PubMed (opens in a new tab) · 4%
- Clickotine, A Personalized Smartphone App for Smoking Cessation: Initial Evaluation - PubMed (opens in a new tab) · 1%
- Long-Term Effectiveness of a Clinician-Assisted Digital Cognitive Behavioral Therapy Intervention for Smoking Cessation: Secondary Outcomes From a Randomized Controlled Trial - PubMed (opens in a new tab) · 1%
The page AI cites most for Clickotine
Brands AI mentions
Mentioned in
